awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34973750-36AC60B7-B6D5-4040-B796-B0117A9AD6C2
Q34973750-36AC60B7-B6D5-4040-B796-B0117A9AD6C2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34973750-36AC60B7-B6D5-4040-B796-B0117A9AD6C2
Sodium-glucose co-transporter 2 (SGLT2) inhibitors: a growing class of antidiabetic agents
P2860
Q34973750-36AC60B7-B6D5-4040-B796-B0117A9AD6C2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34973750-36AC60B7-B6D5-4040-B796-B0117A9AD6C2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4e47669c8a5140950c5e4e909466db5e8b77bbd2
P2860
Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial.